Catalent to acquire gene therapy service firm Paragon
Monday, April 15, 2019 - 15:30
in Mathematics & Economics
The $1.2 billion deal is the latest designed to support the flood of gene therapies in development
The $1.2 billion deal is the latest designed to support the flood of gene therapies in development